KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales (2016 - 2025)

Historic Return on Sales for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to 0.13%.

  • TherapeuticsMD's Return on Sales rose 2100.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.07% for FY2024, which is 20600.0% up from last year.
  • TherapeuticsMD's Return on Sales amounted to 0.13% in Q3 2025, which was up 2100.0% from 0.01% recorded in Q2 2025.
  • TherapeuticsMD's 5-year Return on Sales high stood at 365.39% for Q2 2022, and its period low was 44.81% during Q1 2022.
  • For the 5-year period, TherapeuticsMD's Return on Sales averaged around 12.61%, with its median value being 0.04% (2025).
  • As far as peak fluctuations go, TherapeuticsMD's Return on Sales soared by 3672400bps in 2022, and later crashed by -3651900bps in 2023.
  • Quarter analysis of 5 years shows TherapeuticsMD's Return on Sales stood at 2.68% in 2021, then plummeted by -84bps to 0.43% in 2022, then skyrocketed by 207bps to 1.31% in 2023, then crashed by -84bps to 0.21% in 2024, then crashed by -37bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.01% for Q2 2025, and 0.04% during Q1 2025.